Clinical Trial Update: Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM) [Phase 4]

View source ↗

Summary

This document provides a Phase 4 clinical trial update on the Pneumococcal Conjugate Vaccine 13 (PCV13) for patients with multiple myeloma, noting the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Multiple Myeloma | Phase 4 | Status: ACTIVE_NOT_RECRUITING